{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:59:11Z","timestamp":1761512351125},"reference-count":35,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T00:00:00Z","timestamp":1169510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background: <\/jats:bold> Overweight and hepatic steatosis can increase the risk of hepatocarcinogenesis. In addition, overweight may affect the treatment efficacy of ultrasound\u2010guided percutaneous ablation. We evaluated the impact of overweight on the safety and efficacy of percutaneous ablation to hepatocellular carcinoma (HCC).<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> We enrolled 743 patients with na\u00efve HCC who were treated by percutaneous ablation including ethanol injection, microwave coagulation, and radiofrequency ablation (RFA) between 1995 and 2003. Patients were divided into two groups by body mass index (BMI): 219 overweight patients with BMI&gt;25\u2003kg\/m<jats:sup>2<\/jats:sup> and 524 control patients with BMI\u226425\u2003kg\/m<jats:sup>2<\/jats:sup>. The effects of BMI on complications of percutaneous ablation, HCC recurrence, and overall survival were analyzed, together with others including tumor and liver function\u2010related factors.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> The overweight group required a significantly larger number of sessions by RFA (<jats:italic>P<\/jats:italic>=0.01). Major complications were identified in 8.7% in the overweight group and 7.6% in the control group (<jats:italic>P<\/jats:italic>=0.94). There was no significant difference in cumulative recurrence rate and local tumor\u2010progression rate between the two groups (<jats:italic>P<\/jats:italic>=0.63 and 0.44). Cumulative survival rates at 1, 3, and 5 years were 95.4%, 75.7%, and 57.8%, respectively, in the overweight group and 94.1%, 78.0%, and 58.8% in the control group (<jats:italic>P<\/jats:italic>=0.99).<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> The results indicated that overweight did not increase complications nor affect HCC recurrence and overall survival. However, the number of sessions of RFA was significantly greater in overweight patients, suggesting that overweight was associated with minor technical difficulties.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2006.01420.x","type":"journal-article","created":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T09:28:48Z","timestamp":1169544528000},"page":"360-367","source":"Crossref","is-referenced-by-count":10,"title":["Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma"],"prefix":"10.1111","volume":"27","author":[{"given":"Takamasa","family":"Ohki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Masuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuntaro","family":"Obi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Omata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903113401001"},{"issue":"5","key":"e_1_2_6_3_2","first-page":"S5","article-title":"Primary liver cancer","volume":"127","author":"Bosch FX","year":"2004","journal-title":"worldwide incidence and trends"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220403"},{"issue":"5","key":"e_1_2_6_5_2","first-page":"S27","article-title":"Hepatocellular carcinoma","volume":"127","author":"El\u2010Serag HB.","year":"2004","journal-title":"recent trends in the United States"},{"issue":"5","key":"e_1_2_6_6_2","first-page":"1206","article-title":"Risk factors for hepatocellular carcinoma","volume":"36","author":"Hassan MM","year":"2002","journal-title":"synergism of alcohol with viral hepatitis and diabetes mellitus"},{"issue":"17","key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle EE","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"e_1_2_6_8_2","first-page":"344","article-title":"Obesity and cancer risk","volume":"30","author":"Moller H","year":"1994","journal-title":"a Danish record-linkage study"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.10.005"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11427"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.11.1781"},{"issue":"2","key":"e_1_2_6_12_2","first-page":"229","article-title":"Early and late recurrence after liver resection for hepatocellular carcinoma","volume":"243","author":"Portolani N","year":"2006","journal-title":"prognostic and therapeutic implications"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24432"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ssu.2980090404"},{"issue":"10","key":"e_1_2_6_15_2","first-page":"1124","article-title":"Hepatectomy for hepatocellular carcinoma","volume":"134","author":"Fan ST","year":"1999","journal-title":"the surgeon's role in long-term survival"},{"issue":"3","key":"e_1_2_6_16_2","first-page":"174","article-title":"Interferon therapy reduces the risk for hepatocellular carcinoma","volume":"131","author":"Yoshida H","year":"1999","journal-title":"national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy"},{"issue":"1","key":"e_1_2_6_17_2","first-page":"101","article-title":"Hepatocellular carcinoma and cirrhosis in 746 patients","volume":"197","author":"Livraghi T","year":"1995","journal-title":"long-term results of percutaneous ethanol injection"},{"issue":"5","key":"e_1_2_6_18_2","first-page":"1023","article-title":"Percutaneous ethanol injection therapy for hepatocellular carcinoma","volume":"160","author":"Shiina S","year":"1993","journal-title":"results in 146 patients"},{"issue":"8","key":"e_1_2_6_19_2","first-page":"1694","article-title":"Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma","volume":"85","author":"Seki T","year":"1999","journal-title":"comparison with percutaneous ethanol injection therapy"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20892"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2004.0959.x"},{"issue":"3","key":"e_1_2_6_22_2","first-page":"266","article-title":"Analysis of factors influencing hepatocellular carcinoma detection","volume":"40","author":"Fujishima T","year":"2005","journal-title":"efficient use of computed tomography during arterial portography and during hepatic arteriography"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E"},{"issue":"5","key":"e_1_2_6_24_2","first-page":"S159","article-title":"Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods","volume":"127","author":"Omata M","year":"2004","journal-title":"ethanol injection therapy and radiofrequency ablation"},{"issue":"2","key":"e_1_2_6_25_2","first-page":"335","article-title":"Image\u2010guided tumor ablation","volume":"228","author":"Goldberg SN","year":"2003","journal-title":"proposal for standardization of terms and reporting criteria"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.RVI.0000151141.09597.5F"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24233"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2002.02168.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176350951"},{"issue":"446","key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine JP","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"e_1_2_6_31_2","first-page":"664","article-title":"Cryptogenic cirrhosis and NAFLD","volume":"101","author":"Maheshwari A","year":"2006","journal-title":"are they related?"},{"key":"e_1_2_6_32_2","unstructured":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i\u2010xii 1\u2013253. Available fromhttp:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11234459"},{"issue":"12","key":"e_1_2_6_33_2","first-page":"1456","article-title":"Clinical significance of hepatic resection in hepatocellular carcinoma","volume":"135","author":"Sakon M","year":"2000","journal-title":"analysis by disease-free survival curves"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.16.1523"},{"issue":"6","key":"e_1_2_6_35_2","first-page":"898","article-title":"Obesity and cardiovascular disease","volume":"113","author":"Poirier P","year":"2006","journal-title":"pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21164"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2006.01420.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2006.01420.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T03:45:26Z","timestamp":1697168726000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2006.01420.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,25]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1111\/j.1478-3231.2006.01420.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2006.01420.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,25]]}}}